Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases
dc.contributor.author | Balzarini, Jan | |
dc.contributor.author | Ford, Alan | |
dc.contributor.author | Maguire, Nuala M. | |
dc.contributor.author | John, Jubi | |
dc.contributor.author | Das, Kalyan | |
dc.contributor.author | Arnold, Eddy | |
dc.contributor.author | Dehaen, Wim | |
dc.contributor.author | Maguire, Anita R. | |
dc.contributor.funder | KU Leuven | en |
dc.contributor.funder | National Institutes of Health | en |
dc.contributor.funder | Science Foundation Ireland | en |
dc.date.accessioned | 2019-05-02T15:35:21Z | |
dc.date.available | 2019-05-02T15:35:21Z | |
dc.date.issued | 2019-01-16 | |
dc.date.updated | 2019-05-02T15:18:56Z | |
dc.description.abstract | Acyclic nucleoside phosphonates represent a well-defined class of clinically used nucleoside analogs. All acyclic nucleoside phosphonates need intracellular phosphorylation before they can bind viral DNA polymerases. Recently, a novel class of alpha-carboxynucleoside phosphonates have been designed to mimic the natural 2′-deoxynucleotide 5′-triphosphate substrates of DNA polymerases. They contain a carboxyl group in the phosphonate moiety linked to the nucleobase through a cyclic or acyclic bridge. Alpha-carboxynucleoside phosphonates act as viral DNA polymerase inhibitors without any prior requirement of metabolic conversion. Selective inhibitory activity against retroviral reverse transcriptase and herpesvirus DNA polymerases have been demonstrated. These compounds have a unique mechanism of inhibition of viral DNA polymerases, and provide possibilities for further modifications to optimize and fine tune their antiviral DNA polymerase spectrum. | en |
dc.description.sponsorship | KU Leuven (Grants PF 10/018 and GOA 10/14); National Institutes of Health (Grant P50 GM103368 and Grant R37 AI027690 MERIT Award); | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Balzarini, J., Ford, A., Maguire, N. M., John, J., Das, K., Arnold, E., Dehaen, W. and Maguire, A. (2019) 'Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases', Future Medicinal Chemistry, 11(2), pp. 137-154. doi: 10.4155/fmc-2018-0324 | en |
dc.identifier.doi | 10.4155/fmc-2018-0324 | en |
dc.identifier.endpage | 154 | en |
dc.identifier.issn | 1756-8919 | |
dc.identifier.issn | 1756-8927 | |
dc.identifier.issued | 2 | en |
dc.identifier.journaltitle | Future Medicinal Chemistry | en |
dc.identifier.startpage | 137 | en |
dc.identifier.uri | https://hdl.handle.net/10468/7845 | |
dc.identifier.volume | 11 | en |
dc.language.iso | en | en |
dc.publisher | Future Science | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Technology and Innovation Development Award (TIDA)/05/PICA/B802 TIDA 09/IE/Powder diffraction of pharmaceutical co-crystals/ | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Technology and Innovation Development Award (TIDA)/14/TIDA/2402/IE/Synthesis and biological evaluation of prodrug derivatives of _-carboxynucleosidephosphonate NRTIs (_ -CNPs)/ | en |
dc.relation.uri | https://www.future-science.com/doi/abs/10.4155/fmc-2018-0324 | |
dc.rights | © 2019 Future Science Group | en |
dc.subject | a-carboxynucleoside phosphonate (a-CNP) | en |
dc.subject | Acyclic nucleoside phosphonate (ANP) | en |
dc.subject | Chemotherapeutics | en |
dc.subject | Herpes viruses | en |
dc.subject | HIV | en |
dc.subject | Nucleoside-analog inhibitor | en |
dc.subject | Reverse transcriptase (RT) | en |
dc.subject | Viral DNA polymerase | en |
dc.title | Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases | en |
dc.type | Article (peer-reviewed) | en |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: